Literature DB >> 1500858

The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.

U Moebius1, L K Clayton, S Abraham, S C Harrison, E L Reinherz.   

Abstract

The first immunoglobulin V-like domain of CD4 contains the binding site for human immunodeficiency virus gp120. Guided by the atomic structure of a two-domain CD4 fragment, we have examined gp120 interaction with informative CD4 mutants, both by equilibrium and kinetic analysis. The binding site on CD4 appears to be a surface region of about 900 A2 on the C" edge of the domain. It contains an exposed hydrophobic residue, Phe43, on the C" strand and four positively charged residues, Lys29, Lys35, Lys46, and Arg59, on the C, C', C", and D strands, respectively. Replacement of Phe43 with Ala or Ile reduces affinity for gp120 by more than 500-fold; Tyr, Trp, and Leu substitutions have smaller effects. The four positively charged side chains each make significant contributions (7-50-fold). This CD4 site may dock into a conserved hydrophobic pocket bordered by several negatively charged residues in gp120. Class II major histocompatibility complex binding includes the same region on CD4; this overlap needs to be considered in the design of inhibitors of the CD4-gp120 interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500858      PMCID: PMC2119328          DOI: 10.1084/jem.176.2.507

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.

Authors:  U Olshevsky; E Helseth; C Furman; J Li; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.

Authors:  M R Shalaby; J F Krowka; T J Gregory; S E Hirabayashi; S M McCabe; D S Kaufman; D P Stites; A J Ammann
Journal:  Cell Immunol       Date:  1987-11       Impact factor: 4.868

3.  Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  D S Dimitrov; K Hillman; J Manischewitz; R Blumenthal; H Golding
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.

Authors:  L K Clayton; M Sieh; D A Pious; E L Reinherz
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

5.  Engagement of CD4 and CD8 accessory molecules is required for T cell maturation.

Authors:  F Ramsdell; B J Fowlkes
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

6.  Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.

Authors:  A Ashkenazi; L G Presta; S A Marsters; T R Camerato; K A Rosenthal; B M Fendly; D J Capon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Surface structures involved in target recognition by human cytotoxic T lymphocytes.

Authors:  S C Meuer; R E Hussey; J C Hodgdon; T Hercend; S F Schlossman; E L Reinherz
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

8.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.

Authors:  S Fleury; D Lamarre; S Meloche; S E Ryu; C Cantin; W A Hendrickson; R P Sekaly
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

10.  Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.

Authors:  Q J Sattentau; J Arthos; K Deen; N Hanna; D Healey; P C Beverley; R Sweet; A Truneh
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  63 in total

1.  Structural features of nectin-2 (HveB) required for herpes simplex virus entry.

Authors:  W M Martinez; P G Spear
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein.

Authors:  Shi-Hua Xiang; Peter D Kwong; Rishi Gupta; Carlo D Rizzuto; David J Casper; Richard Wyatt; Liping Wang; Wayne A Hendrickson; Michael L Doyle; Joseph Sodroski
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Selection of an avian retrovirus mutant with extended receptor usage.

Authors:  R A Taplitz; J M Coffin
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Authors:  Ignacio J Juncadella; Renu Garg; Tonya C Bates; Elias R Olivera; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

7.  Neutralization of HIV-1 by redirection of natural antibodies.

Authors:  Maria F Perdomo; Michael Levi; Matti Sällberg; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

8.  Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.

Authors:  S Moir; J Perreault; L Poulin
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.

Authors:  K Zingler; J A Young
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 10.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.